THC pain study for endometriosis pulled before start
NCT ID NCT06834997
First seen Oct 31, 2025 · Last updated Jun 09, 2026 · Updated 36 times
Summary
This study was designed to see if a synthetic THC pill (Marinol) could safely reduce chronic pelvic pain in women with endometriosis. It planned to enroll up to 75 women aged 18-64 and give them THC or a placebo for 8 weeks. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor College of Medicine
Hosuton, Texas, 77030, United States
-
Michael E DeBakey VA Medical Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.